Annual Current Liabilities
$1.63 M
-$373.20 K-18.62%
31 December 2023
Summary:
BioNexus Gene Lab annual total current liabilities is currently $1.63 million, with the most recent change of -$373.20 thousand (-18.62%) on 31 December 2023. During the last 3 years, it has fallen by -$1.74 million (-51.66%). BGLC annual current liabilities is now -51.66% below its all-time high of $3.37 million, reached on 01 December 2020.BGLC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$1.41 M
+$15.50 K+1.11%
30 September 2024
Summary:
BioNexus Gene Lab quarterly total current liabilities is currently $1.41 million, with the most recent change of +$15.50 thousand (+1.11%) on 30 September 2024. Over the past year, it has dropped by -$229.20 thousand (-13.94%). BGLC quarterly current liabilities is now -58.06% below its all-time high of $3.37 million, reached on 01 December 2020.BGLC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.6% | -13.9% |
| 3 y3 years | -51.7% | -39.2% |
| 5 y5 years | +3060.7% | +2642.1% |
BGLC Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.7% | at low | -46.9% | +6.0% |
| 5 y | 5 years | -51.7% | +3060.7% | -58.1% | +3603.9% |
| alltime | all time | -51.7% | +3060.7% | -58.1% | +3603.9% |
BioNexus Gene Lab Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.41 M(+1.1%) |
| June 2024 | - | $1.40 M(-18.5%) |
| Mar 2024 | - | $1.72 M(+5.2%) |
| Dec 2023 | $1.63 M(-18.6%) | $1.63 M(-0.8%) |
| Sept 2023 | - | $1.64 M(-12.4%) |
| June 2023 | - | $1.88 M(+20.0%) |
| Mar 2023 | - | $1.56 M(-22.0%) |
| Dec 2022 | $2.00 M(-13.9%) | $2.00 M(+50.1%) |
| Sept 2022 | - | $1.33 M(-11.2%) |
| June 2022 | - | $1.50 M(-24.3%) |
| Mar 2022 | - | $1.98 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.33 M(-31.0%) | - |
| Dec 2021 | - | $2.33 M(-12.6%) |
| Sept 2021 | - | $2.66 M(+3.5%) |
| June 2021 | - | $2.58 M(-15.1%) |
| Mar 2021 | - | $3.04 M(-10.0%) |
| Dec 2020 | $3.37 M(+6438.0%) | $3.37 M(+8731.4%) |
| Sept 2020 | - | $38.20 K(-17.8%) |
| June 2020 | - | $46.50 K(-1.9%) |
| Mar 2020 | - | $47.40 K(-8.1%) |
| Dec 2019 | $51.60 K(-18.0%) | $51.60 K |
| Dec 2018 | $62.90 K | - |
FAQ
- What is BioNexus Gene Lab annual total current liabilities?
- What is the all time high annual current liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual current liabilities year-on-year change?
- What is BioNexus Gene Lab quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly current liabilities year-on-year change?
What is BioNexus Gene Lab annual total current liabilities?
The current annual current liabilities of BGLC is $1.63 M
What is the all time high annual current liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual total current liabilities is $3.37 M
What is BioNexus Gene Lab annual current liabilities year-on-year change?
Over the past year, BGLC annual total current liabilities has changed by -$373.20 K (-18.62%)
What is BioNexus Gene Lab quarterly total current liabilities?
The current quarterly current liabilities of BGLC is $1.41 M
What is the all time high quarterly current liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly total current liabilities is $3.37 M
What is BioNexus Gene Lab quarterly current liabilities year-on-year change?
Over the past year, BGLC quarterly total current liabilities has changed by -$229.20 K (-13.94%)